A Survey of the Collection, Provision, and Application of Drug Safety Information at Hospitals
10.11256/jjdi.14.170
- VernacularTitle:病院における医薬品の安全性情報の入手・伝達・活用に関する調査
- Author:
Maki Masuyama
;
Hirokazu Hasegawa
;
Mie Ikeda
;
Kazuhiko Mori
;
Keiko Yoshino
;
Yoshiaki Ara
;
Hisanori Miyashita
;
Yasuo Ide
;
Yoshihiko Suzuki
;
Masahiro Hayashi
;
Tsutomu Matsuda
- Publication Type:Journal Article
- Keywords:
drug safety information;
questionnaire survey;
medical representative
- From:Japanese Journal of Drug Informatics
2013;14(4):170-178
- CountryJapan
- Language:English
-
Abstract:
Objective: We conducted a questionnaire survey to comprehend the situation regarding the collection, provision, and utilization of drug safety information at hospitals. In addition, we asked pharmaceutical companies how they select medical institutions to provide drug safety information. We also investigated the current situation of information provision to Tokyo Medial Center by pharmaceutical companies.
Method: A questionnaire was mailed to all hospitals in Japan. The survey was conducted between January 13 and February 10, 2011. Moreover, we asked thirteen pharmaceutical companies by telephone and e-mail about the implementation status of the provision of information and performed a survey at Tokyo Medical Center on the current situation of information provision by pharmaceutical companies regarding revisions to precaution sections in package inserts.
Results: The results of the questionnaire survey (response rate: 41.2%) showed that the major information sources for hospitals were medical representatives (77.8%), Drug Safety Update (50.3%) and direct mails (49.3%). Furthermore, in the case of drugs prescribed exclusively for extramural dispensing, fewer hospitals responded that medical representatives of the pharmaceutical companies provided drug safety information and more hospitals responded that they did not obtain any drug safety information at all, compared with drugs listed in the hospital formularies.
Conclusion: To minimize the risks of drugs, healthcare professionals must collect a wide range of drug safety information and must utilize this information in their medical practice. Therefore, it is important that pharmaceutical companies and regulatory authorities make an effort to provide suitable information dissemination to medical institutions. Furthermore, medical institutions must also strengthen their systems for collecting drug safety information and providing such information to healthcare professionals.
